SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BigKNY3 who wrote (4401)1/7/1998 11:27:00 PM
From: EyeDrMike  Read Replies (1) of 23519
 
"Q: What product launches will we see from Pfizer in 1998?
A: We expect several major launches next year. The first launch will be our broad-spectrum antibiotic Trovan. Second launch should be Viagra. The FDA put it on fast-track review. So that means we could get approval at the end of the first quarter.""

seems to me "could" is a far cry from approval; and i listen to rumors; part of evaluating a company just like anything else. And from what i've read, end of first Q is not even a remote possibility.

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News